Your browser doesn't support javascript.
loading
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Allen, Carl E; Marsh, Rebecca; Dawson, Peter; Bollard, Catherine M; Shenoy, Shalini; Roehrs, Philip; Hanna, Rabi; Burroughs, Lauri; Kean, Leslie; Talano, Julie-An; Schultz, Kirk R; Pai, Sung-Yun; Baker, K Scott; Andolina, Jeffrey R; Stenger, Elizabeth O; Connelly, James; Ramirez, Alyssa; Bryant, Christopher; Eapen, Mary; Pulsipher, Michael A.
Afiliação
  • Allen CE; Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX.
  • Marsh R; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Dawson P; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Bollard CM; The Emmes Corporation, Rockville, MD.
  • Shenoy S; Center for Cancer and Immunology Research, Children's National Health System and Department of Pediatrics, The George Washington University, Washington, DC.
  • Roehrs P; Division of Pediatric Hematology-Oncology, Washington University School of Medicine, St. Louis, MO.
  • Hanna R; Levine Children's Hospital, Carolinas HealthCare System, Charlotte, NC.
  • Burroughs L; Department of Pediatric Hematology and Oncology and BMT, Cleveland Clinic, Cleveland, OH.
  • Kean L; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA.
  • Talano JA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA.
  • Schultz KR; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA.
  • Pai SY; Seattle Children's Hospital, Seattle, WA.
  • Baker KS; Department of Pediatric Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Andolina JR; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Stenger EO; Division of Pediatric Hematology-Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Connelly J; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA.
  • Ramirez A; Seattle Children's Hospital, Seattle, WA.
  • Bryant C; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, NY.
  • Eapen M; Aflac Center and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA.
  • Pulsipher MA; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI.
Blood ; 132(13): 1438-1451, 2018 09 27.
Article em En | MEDLINE | ID: mdl-29997222
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article